The progesterone receptor PROGINS polymorphism is not related to oxidative stress factors in women with polycystic ovary syndrome

Cardiovascular Diabetology

Volumn 6, Issue , 2007, Pages

  Karadeniz, Muammer ^a   Erdogan, Mehmet ^a   Berdeli, Afig ^a   Tamsel, Sadik ^a   Saygili, Fusun ^a   Yilmaz, Candeger ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; FOLLITROPIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROGESTERONE RECEPTOR; PROTEIN PROGINS; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; LIPID;

ADULT; ARTERY INTIMA PROLIFERATION; ARTICLE; BLOOD SAMPLING; BODY MASS; CONTROLLED STUDY; FEMALE; FOLLITROPIN BLOOD LEVEL; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HORMONE DETERMINATION; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; OVARY POLYCYSTIC DISEASE; OXIDATIVE STRESS; BLOOD; GENETICS; GLUCOSE BLOOD LEVEL; METABOLISM; PATHOPHYSIOLOGY; PATIENT SELECTION; PHYSIOLOGY; REFERENCE VALUE;

BLOOD GLUCOSE; C-REACTIVE PROTEIN; FEMALE; GENOTYPE; HUMANS; INSULIN; LIPIDS; OXIDATIVE STRESS; PATIENT SELECTION; POLYCYSTIC OVARY SYNDROME; POLYMORPHISM, GENETIC; RECEPTORS, PROGESTERONE; REFERENCE VALUES;

EID: 36649001440     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-6-29     Document Type: Article

References (46)

1. Chang RJ A practical approach to the diagnosis of polycystic ovary syndrome Am J Obstet Gynecol 2004, 191(3):713-7. 10.1016/ j.ajog.2004.04.045 15467530
2. Legro RS Polycystic ovary syndrome and cardiovascular disease: A premature association? Endocr Rev 2003, 24:302-312. 10.1210/er.2003-0004 12788801
3. Spritzer PM Morsch DM Wiltgen D Polycystic ovary syndrome associated neoplasms Arq Bras Endocrinol Metabol 2005, 49(5):805-10. 16444364
4. Gadducci A Gargini A Palla E Fanucchi A Genazzani AR Polycystic ovary syndrome and gynecological cancers: Is there a link? Gynecol Endocrinol 2005, 20(4):200-8. 10.1080/09513590400021201 16019362
5. Balen A Polycystic ovary syndrome and cancer Hum Reprod Update 2001, 7(6):522-5. 10.1093/humupd/7.6.522 11727859
6. Donaldson CJ Crapanzano JP Watson JC Levine EA Batzer MA PROGINS Alu insertion and human genomic diversity Mutat Res 2002, 25;501(1-2):137-41. 11934445
7. Rousseau Merck MF Misrahi M Loosfelt H Milgrom E Berger R Localization of the human progesterone receptor gene to chromosome 11q22-q23 Hum Genet 1987, 77:280-282. 10.1007/BF00284486 3679212
8. Punyadeera C Verbost P Groothuis P Oestrogen and progestin responses in human endometrium J Steroid Biochem Mol Biol 2003, 84(4):393-410. 10.1016/S0960-0760(03)00061-X 12732285
9. Pike MC Spicer DV Dahmoush L Press MF Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk Epidemiol Rev 1993, 15:17-35. 8405201
10. Greendale GA Reboussin BA Sie A Singh HR Olson LK Gatewood O Bassett LW Wasilauskas C Bush T Barrett-Connor E Effects of estrogen and estrogen-progestin on mammographic parenchymal density. Postmenopausal Estrogen/Progestin Interventions (PEPI) Investigators Ann Intern Med 1999, 130:262-9. 10068383
11. McKenna NJ Kieback DG Carney DN Fanning M McLinden J Headon DR A germline TaqI restriction fragment length polymorphismin the progesterone receptor gene in ovarian carcinoma Br J Cancer 1995, 71:451-5. 7880723
12. Lancaster JM Berchuck A Carney ME Wiseman R Taylor JA Progesterone receptor gene polymorphism and risk for breast and ovarian cancer Br J Cancer 1998, 78:277. 9683307
13. Lancaster JM Wenham RM Halabi S Calingaert B Marks JR Moorman PG Bentley RC Berchuck A Schildkraut JM No relationship between ovarian cancer risk and progesterone receptor gene polymorphism in a population-based, case-control study in North Carolina Cancer Epidemiol Biomarkers Prev 2003, 12:226-7. 12646513
14. Fabjani G Tong D Czerwenka K Schuster E Speiser P Zeillinger R Human progesterone receptor gene polymorphism PROGINS and risk for breast cancer in Austrian women Breast Cancer Res Treat 2002, 72:131-7. 10.1023/ A:1014813931765 12038703
15. Brooks-Asplund EM Tupper CE Daun JM Kenney WL Cannon JG Hormonal modulation of interleukin-6, tumor necrosis factor and associated receptor secretion in postmenopausal women Cytokine 2002, 19:193-200. 10.1006/cyto.2002.1963 12297113
16. Manning PJ Sutherland WH Allum AR de Jong SA Jones SD Effect of hormone replacement therapy on inflammation-sensitive proteins in post-menopausal women with type 2 diabetes Diabet Med 2002, 19:847-852. 10.1046/j.1464-5491.2002.00808.x 12358873
17. The Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS) Hum Reprod 2004, 19(1):41-7. 10.1093/ humrep/deh098 14688154
18. Ferriman D Gallwey JD Clinical assessment of body hair growth in women J Clin Endocrinol Metab 1961, 21:1440-1447. 13892577
19. Matthews DR Hosker JP Rudenski AS Naylor BA Treacher DF Turner RC Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 1985, 28:412-419. 10.1007/BF00280883 3899825
20. Yagi K Lipid peroxides in hepatic, gastrointestinal and pancreatic diseases Free radicals in Diagnostic Medicine New York, NY, Plenum Press Armstrong D 1994:165-169.
21. Miranda KM Espey MG Wink DA A rapid, simple spectrophometric method for simultaneous detection of nitrate and nitrite Nitric Oxide 2001, 5:62-71. 10.1006/niox.2000.0319 11178938
22. Sedlak J Lindsay RH Estimation of total, protein-bound and nonprotein sulfhydryl groups in tissue with Ellman's reagent Anal Biochem 1968, 25:192-205. 10.1016/0003-2697(68)90092-4 4973948
23. Risch HA Bale AE Beck PA Zheng W PGR +331 A/G and increased risk of epithelial ovarian cancer Cancer EpidemiolBiomarkers Prev 2006, 15(9):1738-41. 10.1158/1055-9965.EPI-06-0272
24. Lau KM Mok SC Ho SM Expression of human estrogen receptor-alpha and -beta, progesterone receptor, and androgen receptor mRNA in normal and malignant ovarian epithelial cells Proc Natl Acad Sci USA 1999, 96:5722-7. 21927 10318951 10.1073/pnas.96.10.5722
25. Rowe SM Coughlan SJ McKenna NJ Garrett E Kieback DG Carney DN Headon DR Ovarian carcinoma-associated TaqI restriction fragment length polymorphism in intron G of the progesterone receptor gene is due to an Alu sequence insertion Cancer Res 1995, 1;55(13):2743-5. 7796397
26. Agoulnik IU Tong XW Fischer DC Korner K Atkinson NE Edwards DP Headon DR Weigel NL Kieback DG A germline variation in the progesterone receptor gene increases transcriptional activity and may modify ovarian cancer risk J Clin Endocrinol Metab 2004, 89(12):6340-7. 10.1210/jc.2004-0114 15579801
27. Ohshima H Tatemichi M Sawa T Chemical basis of inflammation-induced carcinogenesis Arch Biochem Biophys 417(1):3-11. 2003 Sep 1. 10.1016/ S0003-9861(03)00283-2 12921773
28. Hofseth LJ Wargovich MJ Inflammation, cancer, and targets of ginseng J Nutr 2007, 137(1):183S-5S. 17182823
29. Bickerton AS Clark N Meeking D Shaw KM Crook M Lumb P Turner C Cummings MH Cardiovascular risk in women with polycystic ovarian syndrome (PCOS) J Clin Pathol 2005, 58(2):151-4. 10.1136/jcp.2003.015271 15677534
30. Refsum H Ueland PM Nygard O Vollset SE Homocysteine and cardiovascular disease Annu Rev Med 1998, 49:31-62. 10.1146/annurev.med.49.1.31 9509248
31. Jacobsen DW Homocysteine and vitamins in cardiovascular disease Clin Chem 1998, 44:1833-1843. 9702993
32. Deepa R Velmurugan K Arvind K Sivaram P Sientay C Uday S Mohan V Serum levels of interleukin 6, C-reactive protein, vascular cell adhesion molecule 1, and monocyte chemotactic protein 1 in relation to insulin resistance and glucose intolerance - the Chennai Urban Rural Epidemiology Study (CURES) Metabolism 2006, 55(9):1232-8. 10.1016/ j.metabol.2006.05.008 16919544
33. Diamanti-Kandarakis E Insulin resistance in PCOS Endocrine 2006, 30(1):13-7. 10.1385/ENDO:30:1:13 17185787
34. Rifici VA Schneider SH Khachadurian AK Stimulation of low-density lipoprotein oxidation by insulin and insulin like growth factor I Atherosclerosis 1994, 107:99-108. 10.1016/0021-9150(94)90145-7 7945563
35. Quiñones Galvan A Muscelli E Catalano C Natali A Sanna G Masoni A Bernardini B Barsacchi R Ferrannini E Insulin decreases circulating vitamin E levels in humans Metabolism 1996, 45:998-1003. 10.1016/ S0026-0495(96)90270-X 8769359
36. Joo MH Maehata E Adachi T Ishida A Murai F Mesaki N The relationship between exercise-induced oxidative stress and the menstrual cycle Eur J Appl Physiol 2004, 93(1-2):82-6. 15243748
37. O MH Maehata E Adachi T Ishida A Murai F Mesaki N The relationship between exercise-induced oxidative stress and the menstrual cycle Eur J Appl Physiol 2004, 93(1-2):82-6. 15243748
38. Bhatia S Shukla R Venkata Madhu S Kaur Gambhir J Madhava Prabhu K Antioxidant status, lipid peroxidation and nitric oxide end products in patients of type 2 diabetes mellitus with nephropathy Clin Biochem 2003, 36(7):557-62. 10.1016/S0009-9120(03)00094-8 14563450
39. Nicotera TM Privalle C Wang TC Oshimura M Barrett JC Differential proliferative responses of Syrian hamster embryo fibroblasts to paraquat-generated superoxide radicals depending on tumor suppressor gene function Cancer Res 1994, 15;54(14):3884-8. 8033111
40. Murrell GA Francis MJ Bromley L Modulation of fibroblast proliferation by oxygen free radicals Biochem J 1990, 1;265(3):659-65. 2154966
41. Randerath K Randerath E Smith CV Chang J Structural origins of bulky oxidative DNA adducts (type II I-compounds) as deduced by oxidation of oligonucleotides of known sequence Chem Res Toxicol 1996, 9(1):247-54. 10.1021/tx950085v 8924599
42. Toyokuni S Okamoto K Yodoi J Hiai H Persistent oxidative stress in cancer FEBS Lett 1995, 16;358(1):1-3. 10.1016/0014-5793(94)01368-B
43. Pelicano H Carney D Huang P ROS stress in cancer cells and therapeutic implications Drug Resist Updat 2004, 7(2):97-110. 10.1016/ j.drup.2004.01.004 15158766
44. Tsai JC Perrella MA Yoshizumi M Hsieh CM Haber E Schlegel R Lee ME Promotion of vascular smooth muscle cell growth by homocysteine: A link to atherosclerosis Proc Natl Acad Sci USA 1994, 91:6369-6373. 44203 8022789 10.1073/pnas.91.14.6369
45. Wild RA Applebaum-Bowden D Demers LM Bartholomew M Landis JR Hazzard WR Santen RJ Lipoprotein lipids in women with androgen excess: Independent associations with increased insulin andandrogen Clin Chem 1990, 36(2):283-9. 2406040
46. Alexandraki K Protogerou AD Papaioannou TG Piperi C Mastorakos Gw Lekakis J Panidis D Diamanti-Kandarakis E Early microvascular and macrovascular dysfunction is not accompanied by structural arterial injury in polycystic ovary syndrome Hormones (Athens) 2006, 5(2):126-36. 16807225